Company Search:
Advanced Search
Sponsored Links
Vermillion Inc Company Snapshot
Vermillion Inc operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vermillion Inc with three other companies in this sector in the United States: Akers Biosciences Incorporation (2015 sales of $2.12 million of which 100% was Diagnostic Screening), American Cannabis Company Inc ($2.80 million ), and Interleukin Genetics, Inc. ($1.44 million ).

Sales Analysis. Vermillion Inc reported sales of $2.18 million for the year ending December of 2015. This represents a decrease of 13.6% versus 2014, when the company's sales were $2.52 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vermillion Inc
  Stock Performance Chart for Vermillion Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 2.33
(Figures in U.S. Dollars)
1 Week -2.9%   13 Weeks 33.1%  
4 Weeks 104.4%   52 Weeks 48.4%  
Vermillion Inc Key Data:
  Ticker: VRML Country: United States
  Exchanges: NAS FRA Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 2,177,000
(Year Ending Jan 2016).
Employees: 54
  Currency: U.S. Dollars Market Cap: 121,785,144
  Fiscal Yr Ends: December Shares Outstanding: 52,268,302
  Share Type: Common Closely Held Shares: 15,792,463
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.